Volume 85 Issue 11 | p. 20 | Concentrates
Issue Date: March 12, 2007

Novo Nordisk Backs Research In China

Department: Business

Novo Nordisk will contribute $2 million to support research on diabetes and to discover biopharmaceuticals in China through an agreement with the Chinese Academy of Sciences. The partners will study protein chemistry, immunology, inflammation, toxicology, oncology, endocrinology, and drug delivery. In 2002, Novo Nordisk set up a 50-person drug discovery lab in Beijing.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment